Rationale for the use of alternating non-cross-resistant chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002470:Cell Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011336:Probability
D000970:Antineoplastic Agents